Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis
Abstract Background Paroxetine is one of the selective serotonin reuptake inhibitors (SSRIs) used in the treatment of premature ejaculation (PE). However, this use is not approved in many countries. The purpose of this systematic review and meta-analysis is to review the efficacy and safety of parox...
Main Authors: | Dong Zhang, Yue Cheng, Kerong Wu, Qi Ma, Junhui Jiang, Zejun Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12894-018-0431-7 |
Similar Items
-
A comparative study of the efficacy of levosulpiride versus paroxetine in premature ejaculation
by: Manish Bathla, et al.
Published: (2020-01-01) -
Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation
by: Abdulmuttalip Simsek, et al.
Published: (2014-10-01) -
Safety and efficacy of “on-demand” tramadol in patients with premature ejaculation: an updated meta-analysis
by: Aditya Prakash Sharma, et al.
Published: (2021-07-01) -
A Randomized Double-blind Placebo-controlled Trial to Assess the Effect of Tamarind seed in Premature Ejaculation
by: Abdulla Homayuonfar, et al.
Published: (2018-01-01) -
Behavioral Therapies for Management of Premature Ejaculation: A Systematic Review
by: Katy Cooper, PhD, et al.
Published: (2015-09-01)